In early 2024, Greg Timblin sought an intern who could bring dedication, curiosity, and a fresh perspective to his startup, Inapill. UC Berkeley undergrad Katie Sie was eager to expand her skills beyond the classroom and into the fast-moving world of therapeutic innovation. QB3’s QWEST program, which pairs students with Bakar Labs tenant companies for hands-on research, offered the perfect match – one that would lead Katie to a prestigious PhD fellowship.